首页|期刊导航|神经药理学报|碳青霉烯类耐药鲍曼不动杆菌的感染现状及耐药机制研究

碳青霉烯类耐药鲍曼不动杆菌的感染现状及耐药机制研究OA

Current Status of Infection and Research on Resistance Mechanisms of Carbapenem-Resistant Acinetobacter Baumannii

中文摘要英文摘要

近年来,随着碳青霉烯类抗生素的临床使用量增加,鲍曼不动杆菌对碳青霉烯类抗菌药物的耐药率呈逐渐上升趋势.耐碳青霉烯类鲍曼不动杆菌目前在全球范围内广泛传播,检出率不断升高,已成为全球重大的公共卫生问题之一.耐多药鲍曼不动杆菌的耐药机制较为复杂,涉及产碳青霉烯酶、主动外排泵的过度表达、外膜蛋白缺失或表达改变、生物膜的形成以及药物作用位点的改变.针对耐多药鲍曼不动杆菌导致的感染,临床治疗可选用的抗菌药物逐渐减少,感染控制难度大,患者病死率高.因此,临床应积极预防耐多药鲍曼不动杆菌感染、优化临床抗菌药物的使用和感染防控,积极寻找新的药物及治疗方案来应对耐碳青霉烯类鲍曼不动杆菌.因此,该文就耐碳青霉烯类鲍曼不动杆菌的感染现状及耐药机制进行综述,为后续抗生素研究、指导临床用药及预防提供相应的科学依据.

In recent years,with the increasing clinical use and intensity of carbapenem antibiotics,the resistance rate of Acinetobacter baumannii to carbapenem antimicrobial agents has shown a gradual upward trend.Carbapenem-resistant Acinetobacter baumannii is now widely distributed globally,with detection rates continuously rising,making it one of the major global public health issues.The resistance mechanisms of carbapenem-resistant Acinetobacter baumannii are complex,involving the production of carbapenemases,overexpression of efflux pumps,deletion or altered expression of outer membrane proteins,biofilm formation,and changes in drug binding sites.For infections caused by multidrug-resistant Acinetobacter baumannii,the number of clinically available antimicrobial agents is diminishing,making infection control challenging and resulting in high patient mortality rates.Therefore,clinicians should actively prevent multidrug-resistant Acinetobacter baumannii,optimize antimicrobial use and infection control,and actively seek new drugs and treatment strategies to address carbapenem-resistant Acinetobacter baumannii.This review summarizes the current status of infections caused by carbapenem-resistant Acinetobacter baumannii and its resistance mechanisms,providing scientific basis for future antibiotic research,clinical guidance,and prevention strategies.

刘子晔;张伟;赵建清

河北北方学院研究生学院,张家口,075000,中国河北北方学院附属第一医院中心实验室,张家口,075000,中国河北北方学院附属第一医院呼吸与危重症医学科,张家口,075000,中国

医药卫生

鲍曼不动杆菌碳青霉烯类耐药感染现状耐药机制

acinetobacter baumanniicarbapenem resistanceinfection statusresistance mechanisms

《神经药理学报》 2026 (1)

58-64,7

10.3969/j.issn.2095-1396.2026.01.008

评论